相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective From the International Transporter Consortium
Sook Wah Yee et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Quantitative Assessment of Liver Steatosis and Affected Pathways with Molecular Imaging and Proteomic Profiling
Yasuyo Urasaki et al.
SCIENTIFIC REPORTS (2018)
Kin 1 kinase localizes at the hyphal septum and is dephosphorylated by calcineurin but is dispensable for septation and virulence in the human pathogen Aspergillus fumigatus
Praveen R. Juvvadi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Transporter Expression in Noncancerous and Cancerous Liver Tissue from Donors with Hepatocellular Carcinoma and Chronic Hepatitis C Infection Quantified by LC-MS/MS Proteomics
Sarah Billington et al.
DRUG METABOLISM AND DISPOSITION (2018)
A novel quantitative immunohistochemistry method for precise protein measurements directly in formalin-fixed, paraffin-embedded specimens: analytical performance measuring HER2
Kristian Jensen et al.
MODERN PATHOLOGY (2017)
Pretreatment With Rifampicin and Tyrosine Kinase Inhibitor Dasatinib Potentiates the Inhibitory Effects Toward OATP1B1-and OATP1B3-Mediated Transport
Sonia Pahwa et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Treatment with proteasome inhibitor bortezomib decreases organic anion transporting polypeptide (OATP) 1 B3-mediated transport in a substrate-dependent manner
Khondoker Aiam et al.
PLOS ONE (2017)
Downregulation of Organic Anion Transporting Polypeptide (OATP) 1B1 Transport Function by Lysosomotropic Drug Chloroquine: Implication in OATP-Mediated Drug-Drug Interactions
Khondoker Alam et al.
MOLECULAR PHARMACEUTICS (2016)
Protein kinase C affects the internalization and recycling of organic anion transporting polypeptide 1B1
Mei Hong et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2015)
Temporal expression of hyaluronic acid and hyaluronic acid receptors in a porcine small intestinal submucosa-augmented rat bladder regeneration model
Fadee G. Mondalek et al.
WORLD JOURNAL OF UROLOGY (2015)
Different Interaction Profiles of Direct-Acting Anti-Hepatitis C Virus Agents with Human Organic Anion Transporting Polypeptides
Tomomi Furihata et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
TC-PTP directly interacts with connexin43 to regulate gap junction intercellular communication
Hanjun Li et al.
JOURNAL OF CELL SCIENCE (2014)
An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome
Yangyang Bian et al.
JOURNAL OF PROTEOMICS (2014)
Interindividual Variability in Hepatic Organic Anion-Transporting Polypeptides and P-Glycoprotein (ABCB1) Protein Expression: Quantification by Liquid Chromatography Tandem Mass Spectroscopy and Influence of Genotype, Age, and Sex
Bhagwat Prasad et al.
DRUG METABOLISM AND DISPOSITION (2014)
A Cancer-Specific Variant of the SLCO1B3 Gene Encodes a Novel Human Organic Anion Transporting Polypeptide 1B3 (OATP1B3) Localized Mainly in the Cytoplasm of Colon and Pancreatic Cancer Cells
Nilay Thakkar et al.
MOLECULAR PHARMACEUTICS (2013)
Drug-Drug Interactions between Rosuvastatin and Oral Antidiabetic Drugs Occurring at the Level of OATP1B1
E. van de Steeg et al.
DRUG METABOLISM AND DISPOSITION (2013)
Erythrocyte plasma membrane-bound ERK1/2 activation promotes ICAM-4-mediated sickle red cell adhesion to endothelium
Rahima Zennadi et al.
BLOOD (2012)
Screening of Antibiotics That Interact with Organic Anion-Transporting Polypeptides 1B1 and 1B3 Using Fluorescent Probes
Hiroaki Yamaguchi et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2011)
Variations in ATP-Binding Cassette Transporter Regulation during the Progression of Human Nonalcoholic Fatty Liver Disease
Rhiannon N. Hardwick et al.
DRUG METABOLISM AND DISPOSITION (2011)
Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake
Mikko Niemi et al.
PHARMACOLOGICAL REVIEWS (2011)
Hepatitis C Virus-related Cirrhosis is a Major Determinant of the Expression Levels of Hepatic Drug Transporters
Ken Ogasawara et al.
DRUG METABOLISM AND PHARMACOKINETICS (2010)
Rapid Modulation of the Organic Anion Transporting Polypeptide 2B1 (OATP2B1, SLCO2B1) Function by Protein Kinase C-mediated Internalization
Kathleen Koeck et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
PhosSNP for Systematic Analysis of Genetic Polymorphisms That Influence Protein Phosphorylation
Jian Ren et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
Na,K-ATPase Subunits as Markers for Epithelial-Mesenchymal Transition in Cancer and Fibrosis
Sigrid A. Rajasekaran et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Major SNP (Q141K) Variant of Human ABC Transporter ABCG2 Undergoes Lysosomal and Proteasomal Degradations
Tomoka Furukawa et al.
PHARMACEUTICAL RESEARCH (2009)
Epithelial sodium channel regulated by differential composition of a signaling complex
Rama Soundararajan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Role of Hepatic Transporters in the Disposition and Hepatotoxicity of a HER2 Tyrosine Kinase Inhibitor CP-724,714
Bo Feng et al.
TOXICOLOGICAL SCIENCES (2009)
SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effects of the SLCO1B1*1B haplotype on the pharmacokinetics and pharmacodynamics of repaglinide and nateglinide
Annikka Kalliokoski et al.
PHARMACOGENETICS AND GENOMICS (2008)
Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1
Stefan Oswald et al.
PHARMACOGENETICS AND GENOMICS (2008)
The effect of SLCO1B1*15 on the disposition of pravastatin and pitavastatin is substrate dependent:: the contribution of transporting activity changes by SLCO1B1*15
Jian Wei Deng et al.
PHARMACOGENETICS AND GENOMICS (2008)
The human ERG1 channel polymorphism, K897T, creates a phosphorylation site that inhibits channel activity
Saverio Gentile et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Lytic infection with vaccinia virus activates caspases in a Bcl-2-inhibitable manner
Marie Kalbacova et al.
VIRUS RESEARCH (2008)
Influence of OATP1B1 genotype on the pharmacokinetics of rosuvastatin in Koreans
J. H. Choi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Different effects of SLCO1B1 polymorphism on the pharmacokinetics of atorvastatin and rosuvastatin
M. K. Pasanen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Bosentan is a substrate of human OATP1B1 and OATP1B3:: Inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin a, rifampicin, and sildenafil
Alexander Treiber et al.
DRUG METABOLISM AND DISPOSITION (2007)
Role of OATP transporters in the disposition of drugs
Mikko Niemi
PHARMACOGENOMICS (2007)
A guided tour into subcellular colocalization analysis in light microscopy
S. Bolte et al.
JOURNAL OF MICROSCOPY (2006)
OATP1B1, OATP1B3, and MRP2 are involved in hepatobiliary transport of olmesartan, a novel angiotensin II blocker
R Nakagomi-Hagihara et al.
DRUG METABOLISM AND DISPOSITION (2006)
Effects of organic anion transporting polypeptide IBI haplotype on pharmacokinetics of pravastatin, valsartan, and temocapril
Kazuya Maeda et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Drug and bile acid transporters in rosuvastatin hepatic uptake: Function, expression, and pharmacogenetics
Richard H. Ho et al.
GASTROENTEROLOGY (2006)
Organic anion transporting polypeptide 1B1 activity classified by SLCO1B1 genotype influences atrasentan pharmacokinetics
DA Katz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment
E Lee et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Effect of OATPIBI (SLCOIBI) variant alleles on the pharmacokinetics of pitavastatin in healthy volunteers
JY Chung et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Single nucleotide polymorphisms in the human norepinephrine transporter gene affect expression, trafficking, antidepressant interaction, and protein kinase C regulation
MK Hahn et al.
MOLECULAR PHARMACOLOGY (2005)
Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells
Y Kameyama et al.
PHARMACOGENETICS AND GENOMICS (2005)
Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics
M Niemi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Evidence for biphasic effects of protein kinase C on serotonin transporter function, endocytosis, and phosphorylation
LD Jayanthi et al.
MOLECULAR PHARMACOLOGY (2005)
Role of organic anion transporter OATP1B1 (OATP-C) in hepatic uptake of irinotecan and its active metabolite, 7-ethyl-10-hydroxycamptothecin: In vitro evidence and effect of single nucleotide polymorphisms
T Nozawa et al.
DRUG METABOLISM AND DISPOSITION (2005)
Human insulin receptor substrate-1 (IRS-1) polymorphism G972R causes IRS-1 to associate with the insulin receptor and inhibit receptor autophosphorylation
AJ McGettrick et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the hepatic uptake of pitavastatin in humans
M Hirano et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Rosuvastatin pharmacokinetics in heart transplant recipients administered an antirejection regimen including cyclosporine
SG Simonson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)
M Niemi et al.
PHARMACOGENETICS (2004)
Functional analysis of single nucleotide polymorphisms of hepatic organic anion transporter OATP1B1 (OATP-C)
M Iwai et al.
PHARMACOGENETICS (2004)
Scansite 2.0: proteome-wide prediction of cell signaling interactions using short sequence motifs
JC Obenauer et al.
NUCLEIC ACIDS RESEARCH (2003)
Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation
RG Tirona et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): A nllele frequencies in the Japanese population and functional analysis
T Nozawa et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Polymorphisms in OATP-C -: Identification of multiple allelic variants associated with altered transport activity among European- and African-Americans
RG Tirona et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide
J König et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Characterization of rapid membrane internalization and recycling
MM Hao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane
J Konig et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2000)
分享论文
